Nathan R Handley
Overview
Explore the profile of Nathan R Handley including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
189
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhang Z, Luo R, Kelly W, Chen J, Donahue S, Ip K, et al.
Prostate Cancer Prostatic Dis
. 2023 Dec;
27(2):339-347.
PMID: 38057610
Background: Identification of emerging molecular biomarkers on circulating tumor cells (CTCs) represents an attractive feature of liquid biopsy that facilitates precision and tailored medicine in the management of metastatic castration-resistant...
2.
Maheu A, Ayubcha S, Handley N
Qual Manag Health Care
. 2023 Aug;
32(4):257-262.
PMID: 37651590
As medicine shifts to a value-based focus, health care providers in inpatient settings are actively seeking approaches to providing high-quality patient care without exacerbating prevailing cost burden. Complementary and integrative...
3.
De Ravin E, Armache M, Campbell F, Rising K, Worster B, Handley N, et al.
Otolaryngol Head Neck Surg
. 2023 Mar;
168(6):1312-1323.
PMID: 36939546
Objective: Evaluate the feasibility and cost-effectiveness of telehealth head and neck cancer (HNC) survivorship care. Data Sources: Ovid MEDLINE, Embase, Scopus, CINAHL. Review Methods: A systematic search for peer-reviewed feasibility...
4.
5.
Baugh C, Dorner S, Levine D, Handley N, Mooney K
Emerg Cancer Care
. 2022 Jul;
1(1):8.
PMID: 35844665
Background: Patients with cancer constitute a large and increasing segment of patients who receive unscheduled hospital-based care due to treatment-related symptoms and disease progression. The initial hospital-based touchpoint for these...
6.
Handley N, Wen K, Gomaa S, Brassil K, Shimada A, Leiby B, et al.
JCO Oncol Pract
. 2022 Apr;
18(7):e1132-e1140.
PMID: 35394806
Purpose: Prostate cancer is the most common cancer among men in the United States. The majority of prostate cancer treatment occurs in the ambulatory setting, and patients and their caregivers...
7.
Handley N, Binder A, Heyer A, Granberg R, Davis G, Nord G, et al.
JCO Oncol Pract
. 2021 Nov;
18(3):e360-e371.
PMID: 34807752
Purpose: The purpose of this study was to develop the Oncology Opportunity Cost Assessment Tool (OOCAT), a survey instrument to evaluate the opportunity costs patients experience when seeking medical oncology...
8.
Handley N, Heyer A, Granberg R, Binder A, Gentsch A, Csik V, et al.
JCO Oncol Pract
. 2021 Oct;
18(4):e610-e619.
PMID: 34678074
Purpose: The COVID-19 pandemic necessitated a rapid expansion of telehealth use in oncology, a specialty in which prior utilization was low in part because of barriers perceived by providers. Understanding...
9.
10.
Russo J, McDougall C, Bowler N, Shimada A, Gross L, Hyatt C, et al.
JCO Precis Oncol
. 2021 Sep;
5.
PMID: 34589662
Purpose: Germline testing (GT) for prostate cancer (PCA) is now central to treatment and hereditary cancer assessment. With rising demand for and shortage of genetic counseling (GC), tools to deliver...